Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Net Cash Flow: 2011-2024

Historic Net Cash Flow for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $23.3 million.

  • Mimedx Group's Net Cash Flow rose 17.45% to $23.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 million, marking a year-over-year increase of 602.82%. This contributed to the annual value of $23.3 million for FY2024, which is 3.58% down from last year.
  • Mimedx Group's Net Cash Flow amounted to $23.3 million in FY2024, which was down 3.58% from $24.2 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Net Cash Flow ranged from a high of $26.7 million in FY2020 and a low of -$21.1 million during FY2022.
  • Its 3-year average for Net Cash Flow is $8.8 million, with a median of $23.3 million in 2024.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 162.15% in 2021, then spiked by 214.57% in 2023.
  • Yearly analysis of 5 years shows Mimedx Group's Net Cash Flow stood at $26.7 million in 2020, then crashed by 162.15% to -$16.6 million in 2021, then decreased by 27.15% to -$21.1 million in 2022, then surged by 214.57% to $24.2 million in 2023, then declined by 3.58% to $23.3 million in 2024.